Cell Care Therapeutics is developing a new class of biologics that are derived from the secreted proteins and exosomes of mesenchymal stromal cells (MSCs). The company’s novel secretome platform harnesses the signaling molecules of MSCs to promote the health of blood vessels and their surrounding tissue. The company is developing its first product for the treatment of diabetic macular edema, the leading cause of vision loss in working age adults.
Company Details
- Founded
- -
- Address
- 750 Royal Oaks Dr, Monrovia,california,united States
- Phone
- (562) 528-3120
- in****@****are.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cell-care.com
- Keywords
- Life Science, Ophthalmology, Exosomes, Secretome, Regenerative Medicine, Stem Cells, Biotechnology.
- HQ
- Monrovia, California
Cell Care Therapeutics Questions
Cell Care Therapeutics's helpline number is (562) 528-3120
Cell Care Therapeutics's website is cell-care.com
Cell Care Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cellcaretherapeutics
Cell Care Therapeutics's industry is
Biotechnology Research
Cell Care Therapeutics's top competitors are
Insception Lifebank Cord Blood Program,
Cell Care Australia,
Valeordo Ltd,
Coopersurgical,
The Bms Group,
Dx Business Innovation (Dxbi),
Aish Support,
Alpha Medical Instruments,
La Biotech Center,
Razo Construction Inc..
Cell Care Therapeutics's support email address is info@cell-care.com
Cell Care Therapeutics's categories are Biotechnology Research
Cell Care Therapeutics's founding year is 2014
